Application period: 5:00AM , Jan. 5, 2023 GMT to 8:00AM , Feb. 28, 2028 GMT
ASAHI KASEI PHARMA OPEN INNOVATION is an open innovation platform started in 2018 to recruit candidates for research collaborations related to drug discovery.
They aim to create innovative new drugs to match their corporate philosophy, ”contribute to life and living for people around the world”. Realizing this goal requires the combined power of many researchers, both internal and external to the company, providing innovation through the integration of their knowledge.
They will accept a broad range of proposals from around the world based upon the programme criteria. They would like to have candidates that will work together with our researchers, who are professionals in drug discovery research, to promote drug discovery research with practical applications.
- Autoimmune disease
- Renal disease
- Neurodegenerative disease
- Bone disease
- Drug discovery platform technology
Asahi Kasei Pharma Corporation will offer selected candidates collaborative research opportunities, with research funding and contribution to the program through their scientists’ research activities. If the program achieves progress, they will consider a separate license agreement that includes payments such as upfront, milestones, and royalties.
